NUTRIBAND INC. - COMMON STOCK

Nutriband CEO Publishes Letter to Shareholders

30 Apr 2025 06:30:00 By Nasdaq GlobeNewswire

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

11 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

04 Apr 2025 16:41:36 By Nasdaq GlobeNewswire

Nutriband Signs Partnership Agreement with Charlotte FC

04 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

21 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

13 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

11 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

07 Feb 2025 07:45:00 By Nasdaq GlobeNewswire

Nutriband Issues Letter to Shareholders

31 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

27 Dec 2024 08:25:00 By Nasdaq GlobeNewswire

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

04 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

04 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

27 Nov 2024 06:00:00 By Nasdaq GlobeNewswire